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persons with psychiatric label, drives patients 
and their families to untested care options, 
than to psychiatric treatment (Wig, 1997). This 
trend will diminish, albeit slowly, when people 
could appreciate the effectiveness of psychiatric 
treatment for mental problems (Jorm , 2000). To 
that end, psychiatrists bear the responsibility of 
delivering effective treatments consistently at 
every possible opportunity. While this is 
largely being carried out, there is a lot of 
scope for improvement, considering the under 
utilization of clozapine for resistant 
schizophrenia and mood stabilizers for all 
phases of bipolar disorder. So is the case 
with proven psychosocial interventions also 
(Kuruvilla, 1998). 
When the circle of family and friends 
directly experience the beneficial effects brought 
out by the psychiatric treatment for persons 
with abnormal behaviour, it sets in motion a 
ripple effect of increased awareness in the 
community. Thus, efficacy of psychiatric treatment 
will have a direct impact on stigma. This 
highlights the need for increased resources for 
quality psychiatric treatment which in turn calls 
for efforts at various levels, including, improving 
undergraduate psychiatry education, establishing 
practice guidelines, modifying the current Mental 
Health Act to make it pragmatic. 
2. Mental Health Education 
While 'effective treatment' may bring 
improvements in mental health care slowly, 
'Mental Health Education' can act quickly, in 
improving certain aspect of Mental Health Care. In 
this era of Information Technology, knowledge 
can be quickly disseminated over large 
geographical area, cutting across socio-
economic, linguistic and cultural barriers through 
media like radio, newspapers,magazines, TVS 
internet. 
These resources are not yet tapped 
adequately by Mental Health Care givers or by 
the government. In fact, adverse and inaccurate 
depictions of mental illness and its treatment 
go unchecked in the mass media like cinemas 
(Wilson etal., 1999). There has to be a focussed 
effort to make available credible scientific 
information about mental illness and its 
treatment, in simple language understandable 
to a common man (Clare, 2000). 
These two efforts, effective treatment and 
mental health education, will take the Mental 
Health Care to a greater height, than short-
term knee jerk reactions. And the onus, in 
these areas, lies with us, the mental health 
care providers. 
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* Correspondence 
RABBfT SYNDROME: AN ACUTE COMPLICATION 
OFNEUROUPTIC MEDICATION 
Sir, 
Apropos Sujata Sethi's case report 
(Sethi,2001) I want to contribute that I reported a 
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case of Rabbit syndrome which occurred twice in 
two different admissions while she received 
highpotency antipsychotics for just one week, the 
response to shift on low potency and adding 
antiparkinson medicines was as good as in her 
case (Jain, 1993) 
I will like to know from the author, if 
extrpyramidal side effects also developed on the 
same day the perioral movements were noted ? 
Extrapyramidal side effects are usually visible after 
one or two days of antipsychotic administration. It 
looks that perioral movements were noted after a 
week of initiation of treatment and then only 
antiparkinson agents were started which mean that 
EPS also occurred on seventh day. 
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SERTRALINE AND BUSPIRONE IN 
ADOLESCENT DELUSIONAL BODY 
DYSMORPHIC DISORDER 
Sir, 
Delusional body dysmorphic disorder 
(BDD) is currently known to respond well to 
serotonin reuptake inhibitors (SRIs). However, 
patients with this disorder show a variable 
response to this class of drugs. We report a case 
of pimozide-resistant delusional BDD who failed 
a subsequent trial of clomipramine but ultimately 
responded to a combination of sertraline and 
buspirone. 
U.K., a 14-year-old girl, had been suffering 
for about 6 months from the belief that her eyes 
were becoming smaller and that her lower lip was 
smaller than her upper lip. The patient was deeply 
convinced about this belief, would spend an hour 
each day examining her face in front of a mirror 
and would apply lipstick to conceal the imagined 
defect. However, this behavior was never ego 
dystonic and she had no insight in to the 
psychological nature of her illness. She avoided 
meeting people, stopped going to the school, 
remained sad and expressed loss of interest, 
hopelessness, worthless and demonstrated 
vegetative signs suggestive of a mild depressive 
episode. During the entire illness, she never had 
obsessive-compulsive symptoms qualifying for a 
disorder. Family history was positive for paranoid 
schizophrenia in father but there was no history 
of any obsessive-compulsive spectrum disorder. 
The patient was diagnosed with delusional 
BDD and treated with pimozide up to 4 mg/day, 
which was discontinued after 5 months in view of 
severe extrapyramidal symptoms and no apparent 
improvement in her beliefs. Subsequently, she was 
treated with clomipramine up to 200 mg/day for 3 
months. Her depressive symptoms improved but 
her beliefs on the imagined defect persisted with 
the same intensity. Therefore, buspirone was 
added for augmentation. At a dose of 200 mg/day 
of clomipramine and 15 mg/day of buspirone, the 
patient had two episodes of generalized seizures. 
An EEG and cranial CT scan did not reveal any 
abnormality to suggest focal brain pathology. 
Clomipramine, due to its seizurogenic potential, 
was replaced with sertraline, which was increased 
to 150 mg/day while buspirone was continued at 
15 mg/day. Within two months of commencing 
this combination, the patient started showing 
improvement. Her frequency of mirror gazing 
decreased and she became more social. In 
another two months, she had rid herself of the 
delusional beliefs and was back to school. 
Currently, she is asymptomatic on this regimen 
for the past two years. 
To our knowledge, this is the first 
adolescent case of BDD where a combination of 
clomipramine and buspirone and sertraline and 
buspirone were tried in the same patient. Similar 
reports in adults have been documented in 
literature (Guggenheim, 2000) while the safety and 
efficacy of sertraline alone in adolescent BDD has 
been shown only anecdotally (Ei-khatib & Dickey, 
1995). In addition, this case offers other interesting 
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